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Hemodynamic monitoring in the
critically ill patient – current status
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Witten/Herdecke, Cologne, Germany
In the critically ill patient, early and effective hemodynamic management including fluid
therapy and administration of vasoactive drugs to maintain vital organ perfusion and oxy-
gen delivery is mandatory. Understanding the different approaches in the management of
critically ill patients during the resuscitation and further management is essential to initiate
adequate context- and time-specific interventions. Treatment of hemodynamic variables
to achieve a balance between organ oxygen delivery and consumption is the cornerstone.
In general, cardiac output is considered a major determinant of oxygen supply and thus
its monitoring is regarded helpful. However, indicators of oxygen requirements are equally
necessary to assess adequacy of oxygen supply. Currently, more and more less or even
totally non-invasive monitoring systems have been developed and clinically introduced,
but require validation in this particular patient population. Cardiac output monitors and
surrogates of organ oxygenation only enable to adequately guide management, as
patient’s outcome is determined by acquisition and interpretation of accurate data, and
finally suitable management decisions. This mini-review presents the currently available
techniques in the field of hemodynamic monitoring in critically ill patients and briefly
summarizes their advantages and limitations.
Keywords: hemodynamics, monitoring, intraoperative, cardiac output, fluid therapy, catecholamines
Since its introduction in the early 1970s the pulmonary artery catheter (PAC) was widely used and
regarded as the “holy grail” in hemodynamic monitoring (1). This device, for the first time, allowed
to measure extended hemodynamic variables, particularly cardiac output, cardiac filling pressures,
and global oxygen transport, in the critically ill patient at the bedside. However, in 1996 when
Connors et al. (2) reported in an observational study based on a matched-pair analysis that the use
of a PAC was associated with an increased mortality and increased utilization of resources, even
a moratorium for the PAC was called for by some authors. Over the following years, several large
randomized controlled trials could not confirm these findings, however, they failed to demonstrate
improved outcome in patients monitored with the PAC (3–6). Thus, up to date no damage but also
no benefit on outcome by using a PAC has been documented. Consequently, a decline in PAC use
over the following years developed (7, 8). Although potentially life-threatening complications during
the catheter placement (e.g., cardiac arrhythmias andmechanical complications) are well described,
data showed that negative impact on outcome is based on the period after the initial phase suggesting
that correct measurement of variables and decisions made are more critical. Nevertheless, the PAC
may still provide important information especially in patients with pulmonary arterial hypertension
and right ventricular failure, however, there is consensus that the PAC should not be routinely used
as the primary means of advanced monitoring (9).
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In general, no specific monitoring device has been found to
reduce mortality in critically ill patients (10), which is not sur-
prising as the conclusions drawn from the hemodynamic variables
obtained and the treatment induced are finally determining. This
statement is confirmed insofar, as there is a convincing body of
evidence that goal-directed optimization of advanced hemody-
namic variables reflecting global blood flow improves patients’
outcome (11, 12).
During the time, when the PAC came under intense debate,
more andmore alternatives and especially less-invasive techniques
were developed and evaluated in experimental and clinical stud-
ies. Besides transpulmonary indicator (e.g., thermal, lithium),
dilution techniques, less-invasive technologies like esophageal
Doppler and uncalibrated pulse contour analysis (based on a
peripheral arterial signal) were introduced. Furthermore, as a
logical step, several manufacturers have promoted and intro-
duced totally non-invasive devices for advanced hemodynamic
monitoring: e.g., thoracic bioimpedance, bioreactance, and ultra-
sound techniques. Although described first in the early 1990s,
non-invasive systems for assessment of radial artery pressure
curves based on the volume clampmethod according to the Peñaz
principle and applanation tonometry are currently intensively
studied in critically ill patients.
In general, cardiac output as major and flow determinant vari-
able of systemic oxygen delivery is often considered helpful in the
management of critically ill patients. However, measurement of
cardiac output per se is only of limited value as its interpretation
(Frank-Starling relation) requires simultaneous information on
cardiac preload and/or fluid responsiveness (as an a priori esti-
mate of the impact of fluid loading on cardiac output). However,
some but not all of the techniques listed below simultaneously
provide information on cardiac output and cardiac preload or
fluid responsiveness, respectively. Since not intended here and
thus without claiming completeness, Table 1 provides an updated
overview on the currently available systems (13).
Before providing an overview on these technologies, briefly
discussing their strengths and weaknesses, an update on the status
quo should be given. Today, as reported in a current survey from
TABLE 1 | Overview on various hemodynamic monitoring devices.
Modality Device Equipment Limitations
Right heart catheterization Pulmonary artery catheter Thermistor-tipped balloon catheter Invasiveness
Special types enabling continuous
monitoring of cardiac output and/or
mixed venous saturation, right
heart ejection or pacing modalities
Mechanical complications, arrhythmias, infections
Central venous oxygen saturation Central venous catheter Intermittent or continuous
measurement of O2-saturation
Mechanical complications, arrhythmias, infections
Not equal to mixed venous O2-saturation
Pulse pressure
Calibrated PiCCOR Thermistor-tipped arterial catheter Hematoma, vessel occlusion with ischemia,
EV100/VolumeViewR Thermistor-tipped arterial catheter embolism, infections
LiDCOR Arterial catheter and lithium sensor see above (cave: lithium levels)
Uncalibrated FloTrac/VigileoR Specific arterial kit Hematoma, vessel occlusion with ischemia,
LiDCO RapidR Specific arterial kit embolism, infections
PulsioFlexR Arterial catheter
PRAM (MostCareR) Specific arterial kit
Non-invasive NexfinR Finger pressure cuff Local swelling, peripheral ischemia
CNAPR Finger pressure cuff, oscillometry Limited accuracy of measurement of absolute cardiac output
T-LineR Radial applanation tonometry
Ultrasound
Doppler
Esophageal Doppler CardioQR Esophageal probe Limited accuracy of measurement of absolute cardiac output
Transthoracic Doppler USCOMR Transthoracic probe
Echocardiography ClariTEER Disposable monoplane echo probe Limited duration of placement, findings operator and
experience dependent
Fick principle
Partial CO2 rebreathing NICOR Rebreathing loop No information on cardiac preload
Dye dilution DDG analyzerR Cutaneous sensor Absolute measurement of cardiac output limited
Bioimpedance/-reactance
Thoracic bioimpedance BioZR Specific electrodes Limited accuracy of measurement of absolute cardiac output
Thoracic bioreactance NICOMR Specific electrodes
Electrical velocimetry AesculonR Specific electrodes
Plethysmography
Plethysmogram variability MASIMOR Specific transcutaneous probe Difficulties in data acquisition in critically ill patients
Accuracy for measurement of absolute cardiac output limited
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Switzerland, 56% of intensivists use transpulmonary thermodi-
lution (1% lithium dilution), 31% a PAC, 9% echocardiography,
and 3% an uncalibrated pulse contour system, respectively (14).
Notably, pulse pressure variation (PPV) and stroke volume vari-
ation (SVV) are mostly used in the Australia and New Zealand,
while esophageal Doppler technology is preferred by anesthetists
in the UK for guiding intraoperative fluid management (15).
In order to assess adequacy of oxygen delivery, central venous
oxygen saturation (ScvO2) as a measure of oxygen transport has
been proposed since the trial by Rivers et al. in 2001 (16). How-
ever, the positive results of a ScvO2-guided treatment on outcome
in patients with sepsis as reported in this monocentric trial were
recently challenged (17). From physiology, central and mixed
venous oxygen saturation cannot be equal, however, the first as
obtained in theV. cava superior can be obtained less invasively and
is commonly used as a surrogate for thematch/mismatch between
oxygen supply and demand. As some authors suggest an average
difference of 7 4% exists between both variables (18), there is
larger difference especially in low cardiac output states (19). Con-
sequently, trending of ScvO2 is probably more clinically relevant
(18) and high values (77.4%) should alert in terms of systemic
inflammation, lactic acidosis, and increase in mortality (20).
Still, thermodilution techniques are regarded as clinical gold
standard for the measurement of cardiac output in critically
ill patients. Transpulmonary thermodilution has been shown to
be equivalent in accuracy when compared to pulmonary artery
thermodilution (21) which is often considered as clinical gold
standard. Volumetric parameters (i.e., intrathoracic blood vol-
ume, global end-diastolic blood volume), which are assessed by
the transpulmonary technique, are regarded superior to static
parameters of cardiac preload, e.g., cardiac filling pressures (22).
Treatment algorithms using transpulmonary indicator dilution
have been described to be associated with a reduction in ICU stay,
less organ dysfunction, and earlier ready for discharge from the
ICU (21). Critically ill patients with subarachnoid hemorrhage,
patients after major burn trauma or cardiac arrest were found
to have more stable organ function when managed by transpul-
monary thermodilution with integrated pulse contour analysis
(21). So far, large randomized, controlled studies in the ICU using
this system aremissing. More recently, flow-directed protocols for
intraoperative hemodynamicmanagement using dynamic param-
eters of fluid responsiveness, i.e., PPV and SVV, have been found
to significantly reduce perioperative complication rates, especially
in patients undergoing major abdominal surgery (23, 24). To
date, PPV is the most reliable predictor of fluid responsiveness
in critically ill patients undergoing mechanical positive-pressure
ventilation without cardiac arrhythmias (25). However, predictive
properties of PPV with respect to fluid responsiveness may be
even higher when considering amplitude of airway pressures (26).
Future studies are warranted to show in how far integration of res-
piratory variables (possibly in an automatedmanner) will improve
the predictive properties of PPV. Although in a lower extent,
PPV may even be helpful for estimating fluid responsiveness in
spontaneously breathing patients as long as no forced respiratory
maneuvers occur (27).
Over the last few years, more systems based on uncalibrated
pulse contour analysis for a beat-to-beat monitoring of cardiac
output are emerging. On the first glance attractive due to the
fact that peripheral (e.g., radial) arterial cannulation and without
need for a reference method, data are conflicting and reliability
of measuring absolute cardiac output correctly is still a matter of
clinical studies (28–30). However, trending of cardiac output by
an uncalibrated technique has been reported to be more reliable
(31). Although intraoperative use of such systems has been found
to reduce complication rates, further studies are mandatory to
assess their accuracy (32) and potential benefit by implementing
in the ICU.
One clinically increasingly attractive technique is the passive
leg raising (PLR) maneuver while using a continuous monitoring
systemwhich allows real-time following of its effects (33). PLR is a
test that predicts whether cardiac output will increase with volume
expansion, i.e., around 300mLof blood from the lower body to the
heart. Since no external fluid is given, hemodynamic effects are
rapidly reversible and there is no risk of fluid overload. However,
several rules should be followed. First, PLR should start from the
semi-recumbent and not the supine position as blood from the
splanchnic region is mobilized by adding trunk lowering. Second,
the PLR effects must be assessed by a direct measurement of car-
diac output and not by the simple measurement of blood pressure.
Furthermore, the cardiac output monitoring technique during
PLR must be able to detect short-term and transient changes
since the PLR effects may vanish quickly. For instance, arterial
pulse contour analysis, echocardiography, esophageal Doppler, or
contour analysis of the volume clamp-derived arterial pressure can
be used. Fourth, cardiac output must be measured not only before
and during PLR but also after PLR when the patient is back in the
semi-recumbent position. As, pain, cough, discomfort, and awak-
ening could provoke adrenergic stimulation, resulting inmistaken
interpretation of cardiac output changes, PLR must be performed
by adjusting the bed and not by manually raising the patient’s legs.
One step further is the use of totally non-invasive techniques
for continuous measurement of blood pressure and cardiac
output in critically ill patients. Finger-cuffed systems (34–37)
which by pulse contour analysis allow continuous monitoring
of cardiac output or radial artery applanation for blood pressure
measurement (38, 39) are currently evaluated in the ICU.
Noteworthy, some of these systems use a reference (e.g.,
oscillometry). Although promising data could be obtained over
the last years, their routine use in severely ill patients cannot be
advocated at this moment.
As a classical Doppler principle-based technology, assessment
of cardiac output by esophageal flow probe requires the velocity-
time-integral and the vessel cross-sectional area (40). Thus by
definition, the esophageal Doppler technique can merely obtain
flow in the descending aorta andmeasurement of absolute cardiac
output is not possible. Furthermore, assumption about the aortic
size may be erroneous. Moreover, the system uses the peak veloc-
ity a surrogate of cardiac contractility and the corrected flow time,
i.e., a dynamic estimate of preload. While earlier studies reported
positive influence on length of stay or complications in patients
undergoing colorectal surgery, newer trials did not show any
benefit from suchmonitoring (41).Data in critically ill patients are
rare and warrant further evaluation (42). Noteworthy, movements
may affect the precision of readings derived from the esophageal
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Doppler. Another approach is a supra-sternal ultrasound probe
using the flow profile of the ascending aorta. Asmentioned above,
two main sources may explain the inferiority to thermodilution
techniques for measurement of cardiac output which are related
to the Doppler measurement of aortic blood flow (i.e., the velocity
time interval) and estimation of the aortic cross-sectional area
which is derived from an algorithm based on patient size and has
nothing to do with Doppler. Data suggest that this technique has
the ability to track cardiac output over time properly, however,
factors like patient age has significant impact on its accuracy (43).
Although transesophageal echocardiography is not a classi-
cal monitoring technique and normally applicable intermittently,
a miniaturized (5.5mm diameter), disposable transesophageal
echocardiography probe which may be kept in situ for up to
72 h has recently been introduced into the market. Although this
method is gaining popularity as a continuousmode of echocardio-
graphic assessment in critical care, it is clearly operator-dependent
and needs further evaluation in anesthesia and intensive care (44).
A complete other approach are non-invasive Fick-principle-
based techniques. For instance, transcutaneous assessment of sol-
uble indicators (e.g., indocyanine green) has been suggested for
measurement of cardiac output. In this technique, (peripheral)
venous indicator injection and downstream concentration mea-
surement (i.e., by a finger sensor) allow recording concentration-
time curves after adequate mathematical analysis cardiac output.
However, the indicator concentration is obtained indirectly from
optical densities and the relation between both has primarily been
derived in healthy volunteers. Since absolute concentrations are
mandatory for correct assessment of cardiac output and since
physical properties of the skin and other tissues may significantly
differ from healthy humans, data in critically ill patients were not
convincing (45). Another Fick-principle-derived technique is the
carbon dioxide rebreathing system. Introduced in 1999 (46), the
system uses the differential Fick partial rebreathing technique to
measure cardiac output in intubated and mechanically ventilated
patients. Decreased correlation between this technique and pul-
monary artery thermodilution has been reported in high cardiac
output states, low minute ventilation, increased intrapulmonary
shunt, and severe chest trauma (47). Besides these drawbacks,
the system does not provide information on cardiac preload
and, thus, its use particularly in critically ill patients cannot be
recommended.
Both, bioreactance and bioimpedance are non-invasive meth-
ods for estimation of cardiac output. Known for many decades,
thoracic bioimpedance allows continuous estimation of cardiac
output based on the specific electric resistance of the thorax which
changes during the cardiac cycle. A small current is transmitted
between electrodes placed on the lower thorax and neck, and the
voltage is measured. The electric impedance is derived from the
voltage, and is inversely proportional to aortic blood flow. The
accuracy of thoracic bioimpedance is affected by alterations in
extravascular lung water, respiratory cycle-dependent alterations
in venous blood flow, increased aortic stiffness, interference from
the mechanical ventilator, and movement of the electrodes. Data
on the validity of thoracic bioimpedance in relation to ther-
modilution estimation of cardiac output have been conflicting
and refinements in this technique are required (48). A simi-
lar approach, electrical velocimetry (49, 50), is a bioimpedance
method of CO determination measuring changes in transthoracic
impedance during cardiac ejection to calculate stroke volume. The
device is based on emission of a high-frequency (50 kHz) and
low-amperage (2mA) alternating electrical current of constant
amplitude via a pair of surface electrodes across the left side of
the thorax. So far, inconsistent data in critically ill patients were
reported (51, 52).
While the bioimpedance measures changes in amplitude,
bioreactance relies on changes in signal frequency. Thoracic
biorectance is more refined than thoracic bioimpedance as the
ability to accurately measure phase shifts is less dependent on
external noise and electrical interference. First data comparing
thoracic biorectance to thermodilution techniques suggests that
the methods are comparable (53, 54). However, adequate clinical
studies are still required to validate the utility of bioreactance and
bioimpedance in critically ill patients.
Last but not least, pulse oximetry as a fully non-invasive tech-
nique may be a helpful tool in assessing hemodynamics (55).
In principle, plethysmographic waveform analysis requires spe-
cific tools and software that are not yet widely available. The
plethysmographic variability index is based on perfusion index
variations during the respiratory cycle and allows automated and
continuous calculation of the respiratory variations in the pulse
oxymeter waveform amplitude. Data from the operative setting
were promising, however, the system is less reliable in critically ill
patients and in about one-tenth of vasopressor-dependent patients
no adequate signal quality could be obtained (56).
In conclusion, independently the methodological considera-
tions and requirements to guarantee adequate accuracy, calibrated
systems are still most reliable for the measurement of cardiac
output in critically ill patients. However, the monitoring system
per se is not outcome relevant but the underlying treatment algo-
rithms aremore important. Up to date, it seems indicated thatwith
higher patients’ morbidity application of non-invasive techniques
should be held restrictive (57). While without any doubt existing
monitoring devices will be refined and new techniques developed,
the future will show which treatment strategy does match the best
requirements to improve outcome of critically ill patients.
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